FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
Main Authors: | Jordan McDonald, BA, Chine-Yu Chuang, BA, J. Kevin Hicks, PharmD, PhD, Darcy K. Berry, MS, CGC, Iman Imanirad, MD, Anupam Rishi, MD, Jessica M. Frakes, MD, Sarah E. Hoffe, MD, Seth Felder, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109421000750 |
Similar Items
-
Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management
by: Leila T. Tchelebi MD, et al.
Published: (2020-10-01) -
A Case of Radiation Recall Myositis and Neuropathy in Locally Advanced Rectal Cancer
by: Charles T. Lee, MD, PharmD, et al.
Published: (2021-11-01) -
Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study
by: Piero Del Boccio, PhD, et al.
Published: (2017-04-01) -
IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
by: Shalini Moningi, MD, et al.
Published: (2020-05-01) -
Effect of Carbogen to Chemoradiation in Volume of Rectal Cancer
by: Christina Hari Nawangsih, et al.
Published: (2020-06-01)